Knowledge Base Retrieval and Recall for siRNA Nucleic Acid

Data Characteristics

siRNA nucleic acid drug product data comes from public databases (e.g., NCBI, Ensembl, DrugBank), internal pharmaceutical R&D reports, clinical trial data, patent literature, and professional journal articles. This data updates frequently, especially clinical trial progress and patent application information. Document structures vary. This includes structured data (e.g., gene sequences, target information, drug structures, IC50, EC50 values), semi-structured data (e.g., clinical trial protocols, adverse reaction reports), and unstructured text (e.g., paper abstracts, expert reviews). Fields and units are specific. Examples include gene identifiers (Entrez Gene ID, Ensembl ID), nucleic acid sequences (5'-UTR, CDS, 3'-UTR), drug concentration units (nM, µM), dosage units (mg/kg), and pharmacokinetic parameters (t1/2, Cmax).

Constraints on Knowledge Base Retrieval and Recall

The high update frequency of siRNA nucleic acid drug data requires the knowledge base to support efficient incremental updates and version management. This ensures timely retrieval results. Diverse document structures necessitate flexible data parsing and embedding strategies. Structured data can be directly mapped. Unstructured text requires more complex preprocessing and chunking. Specific fields and units demand accurate identification and standardization during the knowledge base's preprocessing stage. This avoids retrieval errors due to inconsistent units. For instance, converting drug concentration units from different literature sources to nM improves retrieval accuracy. Varying sequence lengths and specialized biological terminology impose higher demands on text chunking granularity and semantic understanding. This ensures critical gene targets and mechanisms of action remain intact.

Configuration Settings

Configuration Item	Suggested Value	Rationale
`Chunk size`	`500–800 characters`	Balances the completeness of siRNA sequences and related descriptions, preventing truncation of key information.
`Chunk Overlap Length`	`50–100 characters`	Ensures contextual continuity, especially when describing mechanisms of action and experimental data.
`Recall count`	`Top 8–12 entries`	Considers the complexity of siRNA pharmacology information, increasing recall to cover more relevant context.
`Similarity threshold`	`0.75–0.85`	Effectively filters highly relevant results for specialized terminology and sequence similarity.
`Rerank result count`	`Top 5 entries`	Selects the most critical few items through reranking while ensuring information coverage.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Provides sufficient parsing time for large clinical trial reports or patent documents, preventing timeouts.

Common Pitfalls

Retrieval results contain many irrelevant genes or target information. This happens when gene identifiers in the input query are not preprocessed or standardized.
Recalled document segments lack critical dosage or concentration values. This occurs when the chunking strategy is too coarse, separating numerical values from their context.
Queries for pharmacokinetic parameters of specific siRNA drugs are slow or time out. This happens when large structured data files are not effectively indexed or parsing times out.

How to Verify Configuration

Test queries containing specific gene sequences, targets, and drug concentration units. Check the accuracy and completeness of the returned results.
Simulate queries for data with different update frequencies (e.g., latest clinical trial progress). Verify the knowledge base recalls the most recent information.
Confirm that returned results include all key fields (e.g., IC50 values, t1/2 parameters). Check that units are consistent.

The values provided are common starting points. Measure them against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.